By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GI Dynamics 

Boston  Massachusetts    U.S.A.
Phone: 617-454-6025 Fax:


Medical Device

Company News
GI Dynamics (GID.AX) Announces Additional Members To Its Scientific Advisory Board 6/20/2017 7:32:28 AM
GI Dynamics (GID.AX) Announces $5 Million Convertible Note Financing With Crystal Amber Fund 6/16/2017 8:52:59 AM
GI Dynamics (GID.AX) Release: First Data Derived From ABCD Worldwide Endobarrier Registry Presented At American Diabetes Association Shows Sustained Metabolic Improvements In Patients With Obesity And Type 2 Diabetes At Six Months Post-Explant 6/12/2017 6:49:39 AM
GI Dynamics (GID.AX) Announces Change To Board Of Directors 6/2/2017 10:10:18 AM
GI Dynamics (GID.AX) Release: Meta-Analysis Show Endobarrier Improves Glycemic Control, Induces Weight Loss In Patients With Type 2 Diabetes And Obesity 5/23/2017 5:26:24 AM
GI Dynamics (GID.AX) Announces EndoBarrier CE Mark Suspension 5/18/2017 10:23:32 AM
GI Dynamics (GID.AX) Announces Access to 2017 Annual Meeting Of Stockholders And Corporate Update 5/18/2017 10:21:41 AM
GI Dynamics (GID.AX) Selects Allenby Capital To Explore AIM Listing Option 5/3/2017 9:22:53 AM
GI Dynamics (GID.AX) To Release 2016 Annual Report And Host Webcast For Year Ending 31 December 2016 3/23/2017 6:32:08 AM
GI Dynamics (GID.AX) Announces Scientific Advisory Board Members To Further Scientific Understanding Of EndoBarrier 3/13/2017 8:29:29 AM